Previous study demonstrated that intracerebroventricular administration of IL-6 induces depression-like behavior by activating STAT3-dependent regulation of serotonin transporter function, highlighting the interplay between IL-6 elevation and STAT3 signaling in mood dysregulation [47]. Here, IL6 is linked to depressive symptom measurement.